Efficacy and Safety of Molnupiravir Treatment for COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

Efficacy and Safety of Molnupiravir Treatment for COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Published:2023-08 Issue:2 Volume:62 Page:106870
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Tian Fangyuan^ORCID,Feng Qiyi,Chen Zhaoyan

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference38 articles.

1. Life expectancy changes since COVID-19;Schöley;Nat Hum Behav,2022

2. Safety and efficacy of COVID-19 vaccines in children and adolescents: A systematic review of randomized controlled trials;Tian;J Med Virol,2022

3. WHO. Coronavirus disease COVID-19. Geneva: World Health Organization. https://www.who.int/emergencies/diseases/novel-coronavirus-2019 [accessed 12 January 2023].

4. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study;Lancet Respir Med,2022

5. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study;Huang;Lancet Respir Med,2022

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 replication and drug discovery;Molecular and Cellular Probes;2024-10

2. Effectiveness and safety of molnupiravir in the intended-use population: an observational cohort study;Clinical Microbiology and Infection;2024-10

3. A step toward Molnupiravir, COVID-19 Antiviral, detection using Cauliflower-Like cobalt Sulfide-Decorated carbon nanotube modified glassy carbon electrodes;Microchemical Journal;2024-09

4. The safety of antivirals and neutralising monoclonal antibodies used in prehospital treatment of Covid-19;Journal of Infection;2024-09

5. Molnupiravir for the treatment of COVID-19 outpatients: An updated meta-analysis;Journal of Microbiology, Immunology and Infection;2024-06